Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As GHTF Ends, Industry Cautiously Optimistic On Future Harmonization Progress Under IMDRF

This article was originally published in The Gray Sheet

Executive Summary

As the Global Harmonization Task Force held its final meeting last week in Tokyo, members of industry met separately to discuss how GHTF’s work will be carried on by the International Medical Device Regulators Forum.

Advertisement

Related Content

Single-Audit, UDI And Software International Harmonization Docs Finalized
IMDRF Issues Proposed Guidances On Device Auditors, Global UDI System
International Regulators Forum Adds To Ambitious Policy Agenda
Regulatory News In Brief
With Transition To IMDRF, Focus Shifts To Convergence On Discrete Regulatory Practices
Device Harmonization Efforts In Asia Still Far From Implementation And Enforcement
Regulatory News In Brief
International News In Brief
Global Harmonization Task Force To Disband As Focus Shifts To Implementation

Topics

Advertisement
UsernamePublicRestriction

Register

MT031697

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel